Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-Experienced Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00466258
What this trial is testing

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV InfectionsDiffuse Large B Cell Lymphoma
PETHEMA Foundation 50
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Large-scale testing (Phase 3)Study completedNCT02475629
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV

Who this might be right for
HIV
TaiMed Biologics Inc. 40
Not applicableStudy completedNCT00002217
What this trial is testing

Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00059358
What this trial is testing

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 16
Large-scale testing (Phase 3)Study completedNCT00528892
What this trial is testing

Switching From PI to RALtegravir in HIV Stable Patients

Who this might be right for
HIV Infections
Hospital Clinic of Barcelona 282
Testing effectiveness (Phase 2)Study completedNCT01199939
What this trial is testing

The Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
Tibotec, Inc 54
Not applicableStudy completedNCT00006494
What this trial is testing

Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 14
Testing effectiveness (Phase 2)Study completedNCT00089466
What this trial is testing

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Active Not RecruitingNCT02362503
What this trial is testing

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Who this might be right for
HIV Infections
ViiV Healthcare 371
Testing effectiveness (Phase 2)Study completedNCT00113282
What this trial is testing

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 57
Testing effectiveness (Phase 2)Study completedNCT00784147
What this trial is testing

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 113
Not applicableStudy completedNCT00002155
What this trial is testing

A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 600
Large-scale testing (Phase 3)Study completedNCT00844519
What this trial is testing

Effect of Maraviroc on Endothelial Function in HIV-Infected Patients

Who this might be right for
HIV InfectionCardiovascular DiseaseInflammation+1 more
University of California, San Francisco 52
Large-scale testing (Phase 3)Study completedNCT01579474
What this trial is testing

Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

Who this might be right for
Hepatitis C
Boehringer Ingelheim 131
Post-approval studies (Phase 4)Study completedNCT00415090
What this trial is testing

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

Who this might be right for
HIV Infections
Hospital de Calella 28
Post-approval studies (Phase 4)Study completedNCT00470210
What this trial is testing

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Who this might be right for
Hepatitis CHIV Infections
Germans Trias i Pujol Hospital 10
Post-approval studies (Phase 4)UnknownNCT00214435
What this trial is testing

Once Daily 3TC, Efavirenz and ddI for HIV Infection

Who this might be right for
HIV InfectionAIDS
407 Doctors 120
Not applicableStudy completedNCT00615563
What this trial is testing

Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

Who this might be right for
HIV Infections
Boehringer Ingelheim 246
Testing effectiveness (Phase 2)Study completedNCT00704405
What this trial is testing

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 285
Next Page